Lanean...

Effect of sarpogrelate treatment on the prognosis after endovascular therapy for critical limb ischemia

5-Hydroxytryptamine type 2 antagonists are used to treat symptomatic peripheral arterial disease. However, it remains unknown as to whether the administration of sarpogrelate, a 5-hydroxytryptamine type 2 antagonist, improves the prognosis after endovascular therapy for critical limb ischemia (CLI)....

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Takahara, Mitsuyoshi, Kaneto, Hideaki, Katakami, Naoto, Iida, Osamu, Matsuoka, Taka-aki, Shimomura, Iichiro
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer Japan 2013
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4085500/
https://ncbi.nlm.nih.gov/pubmed/23494607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00380-013-0334-1
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!